Author

Louise S. Brackenbury

Observed names: L. Brackenbury, L. S. Brackenbury, L.S Brackenbury, Louise Brackenbury, Louise S Brackenbury

Institution: Charles River Laboratories (United Kingdom)

Observed institutions: The Pirbright Institute, University of Bristol, Charles River Laboratories (United Kingdom), Imperial College London

OpenAlex ID: A5064599125

Consistent beneficial effects of killer cell immunoglobulin‐like receptor 2DL3 and group 1 human leukocyte antigen‐C following exposure to hepatitis C virus†

2009 · Susanne Knapp, Usama Warshow, et al. · Hepatology · 157

Differential effects of bovine viral diarrhoea virus on monocytes and dendritic cells

2003 · E. J. Glew, B. V. Carr, et al. · Journal of General Virology · 81

Alpha/Beta and Gamma Interferons Are Induced by Infection with Noncytopathic Bovine Viral Diarrhea Virus In Vivo

2002 · B. Charleston, L. S. Brackenbury, et al. · Journal of Virology · 68

Aspects of the innate and adaptive immune responses to acute infections with BVDV

2003 · L.S Brackenbury, B.V Carr, et al. · Veterinary Microbiology · 58

Identification of a Cell Population That Produces Alpha/Beta Interferon In Vitro and In Vivo in Response to Noncytopathic Bovine Viral Diarrhea Virus

2005 · L. S. Brackenbury, B. V. Carr, et al. · Journal of Virology · 27

Neisseria lactamica Selectively Induces Mitogenic Proliferation of the Naive B Cell Pool via Cell Surface Ig

2010 · Andrew T Vaughan, Louise S Brackenbury, et al. · The Journal of Immunology · 22

Fibrinogen is localized on dark zone follicular dendritic cells in vivo and enhances the proliferation and survival of a centroblastic cell line in vitro

2007 · Eric A Lefevre, Wayne R Hein, et al. · Journal of Leukocyte Biology · 16

Infection of cattle with Theileria parva induces an early CD8 T cell response lacking appropriate effector function

2008 · E. Fiona Houston, E.L. Taracha, et al. · International Journal for Parasitology · 9

Abstract 3794: Developing an mRNA nanomedicine platform to democratise therapeutic antibodies

2025 · Dan Rocca, Roxana Redis, et al. · Cancer Research · 2

FRI0002 Pharmacodynamic Effects of the CD22-Targeted Monoclonal Antibody Epratuzumab on B Cells in Cynomolgus Monkeys and in Patients with Systemic Lupus Erythematosus

2015 · A. Shock, B. Kilgallen, et al. · Annals of the Rheumatic Diseases · 2

6 Pre-clinical pharmacodynamic biomarker assays of immune modulation can translate to inform exploratory endpoints of target engagement in first-in-human clinical trial stages of drug discovery

2020 · Russell Garland, Christopher Kirkham, et al. · Regular and Young Investigator Award Abstracts · 1

Abstract 4802: CAR-T cell therapy workflow for discovery and development

2025 · David Cobeta Lopez, Benita Quist, et al. · Cancer Research

Abstract 5839: Mimicking the immunosuppressive tumor microenvironment: a complex primary immune cell tumor killing assay to support candidate vaccine or immunomodulator screening

2025 · Oliver J. Brand, Elizabeth Lieverse, et al. · Cancer Research

Abstract 2824: In vitro tumor killing assays for predicting cellular therapeutic efficacy

2020 · Robert Nunan, Michelle Yap, et al. · Cancer Research

Abstract 2811: A translational immuno-oncology platform to model the tumor microenvironmentin vitro

2019 · Louise S. Brackenbury, S. Rhiannon Jenkinson, et al. · Tumor Biology

Abstract 2811: A translational immuno-oncology platform to model the tumor microenvironment in vitro

2019 · Louise S. Brackenbury, S. Rhiannon Jenkinson, et al. · Cancer Research

Moraxella catarrhalis Adhesin UspA1-derived Recombinant Fragment rD-7 Induces Monocyte Differentiation to CD14+CD206+ Phenotype

2014 · Qi Xie, Louise S. Brackenbury, et al. · PLoS ONE

Works count: 17

Citation count: 443

H-index: 8

I10-index: 7